569 related articles for article (PubMed ID: 25988884)
1. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
[TBL] [Abstract][Full Text] [Related]
2. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism.
Okada K; Yamaguchi K; Chiba K; Miyake H; Fujisawa M
Aging Male; 2014 Jun; 17(2):72-5. PubMed ID: 24533913
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA;
J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials.
Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y
Andrologia; 2017 May; 49(4):. PubMed ID: 27389320
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan.
Shigehara K; Konaka H; Koh E; Izumi K; Kitagawa Y; Mizokami A; Nakashima T; Shimamura M; Iwamoto T; Namiki M
Aging Male; 2015; 18(3):169-74. PubMed ID: 26075538
[TBL] [Abstract][Full Text] [Related]
7. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
[TBL] [Abstract][Full Text] [Related]
8. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea.
Shigehara K; Konaka H; Sugimoto K; Nohara T; Izumi K; Kadono Y; Namiki M; Mizokami A
Aging Male; 2018 Jun; 21(2):99-105. PubMed ID: 28920756
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment patterns of testosterone replacement medications.
Donatucci C; Cui Z; Fang Y; Muram D
J Sex Med; 2014 Aug; 11(8):2092-9. PubMed ID: 24909541
[TBL] [Abstract][Full Text] [Related]
10. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
11. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and longevity.
Comhaire F
Andrologia; 2016 Feb; 48(1):65-8. PubMed ID: 25892327
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study).
Kato Y; Shigehara K; Kawaguchi S; Izumi K; Kadono Y; Mizokami A
Andrologia; 2020 Oct; 52(9):e13768. PubMed ID: 32706428
[TBL] [Abstract][Full Text] [Related]
14. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
15. Profile of serum testosterone levels after application of testosterone ointment (glowmin) and its clinical efficacy in late-onset hypogonadism patients.
Amano T; Imao T; Takemae K; Iwamoto T; Yamakawa K; Baba K; Nakanome M; Sugimori H; Tanaka T; Yoshida K; Katabami T; Tanaka M
J Sex Med; 2008 Jul; 5(7):1727-36. PubMed ID: 18093097
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
17. [Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients].
Taniguchi H; Kawa G; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2009 Dec; 55(12):741-4. PubMed ID: 20048556
[TBL] [Abstract][Full Text] [Related]
18. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
Amano T
Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
[TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
[TBL] [Abstract][Full Text] [Related]
20. Late-life onset hypogonadism: a review.
Bassil N; Morley JE
Clin Geriatr Med; 2010 May; 26(2):197-222. PubMed ID: 20497841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]